{"id":"https://openalex.org/W2409347488","doi":null,"title":"Influence of fibrinogen degradation products on the action of amphetamine in the central nervous system.","display_name":"Influence of fibrinogen degradation products on the action of amphetamine in the central nervous system.","alternate_titles":[],"publication_year":1977,"publication_date":"1977-05-01","ids":{"openalex":"https://openalex.org/W2409347488","mag":"2409347488","pmid":"https://pubmed.ncbi.nlm.nih.gov/560684"},"language":"en","primary_location":{"id":"pmid:560684","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/560684","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Polish journal of pharmacology and pharmacy","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2409347488"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114151925","display_name":"Jakub Zwoli\u0144ski","orcid":"https://orcid.org/0000-0001-9245-5552","observed_orcids":["https://orcid.org/0000-0001-9245-5552"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Zwoli\u0144ski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5113760660","display_name":"W Buczko","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Buczko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1222,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.30747581,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"29","issue":"3","first_page":"313","last_page":"319"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fibrinogen-degradation-products","display_name":"fibrinogen degradation products","score":1.0},{"id":"https://openalex.org/keywords/amphetamine","display_name":"amphetamine","score":0.9769999980926514},{"id":"https://openalex.org/keywords/central-nervous-system","display_name":"central nervous system","score":0.7730000019073486},{"id":"https://openalex.org/keywords/locomotor-activity","display_name":"locomotor activity","score":0.9779999852180481},{"id":"https://openalex.org/keywords/stereotyped-behavior","display_name":"stereotypy","score":0.9850000143051147},{"id":"https://openalex.org/keywords/haloperidol-induced-catalepsy","display_name":"haloperidol-induced catalepsy","score":0.9089999794960022},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.8479999899864197},{"id":"https://openalex.org/keywords/homovanillic-acid","display_name":"homovanillic acid","score":0.9909999966621399},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":0.9129999876022339},{"id":"https://openalex.org/keywords/hippocampus","display_name":"hippocampus","score":0.8769999742507935},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.9959999918937683},{"id":"https://openalex.org/keywords/neuromodulators","display_name":"neuromodulators","score":0.6039999723434448}],"concepts":[{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.9343831539154053},{"id":"https://openalex.org/C2779459141","wikidata":"https://www.wikidata.org/wiki/Q1198115","display_name":"Stereotypy","level":4,"score":0.698740541934967},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.673684298992157},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6435233354568481},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.6103423237800598},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5733669996261597},{"id":"https://openalex.org/C2775841634","wikidata":"https://www.wikidata.org/wiki/Q903566","display_name":"Homovanillic acid","level":4,"score":0.5438182950019836},{"id":"https://openalex.org/C2780476085","wikidata":"https://www.wikidata.org/wiki/Q918193","display_name":"Catalepsy","level":4,"score":0.5350568890571594},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.5342490077018738},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.496218740940094},{"id":"https://openalex.org/C2781005078","wikidata":"https://www.wikidata.org/wiki/Q424442","display_name":"Methysergide","level":4,"score":0.4693867862224579},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3973696231842041},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38770371675491333},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.17871657013893127},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11631041765213013},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005338","descriptor_name":"Fibrin Fibrinogen Degradation Products","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013239","descriptor_name":"Stereotyped Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:560684","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/560684","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Polish journal of pharmacology and pharmacy","raw_type":"Journal Article"},{"id":"mag:2409347488","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/560684","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1995195137","https://openalex.org/W2398486522","https://openalex.org/W2027754968","https://openalex.org/W2407880486","https://openalex.org/W2396570721","https://openalex.org/W2186109395","https://openalex.org/W2416040201","https://openalex.org/W2095297084","https://openalex.org/W2013566224","https://openalex.org/W1983074000"],"abstract_inverted_index":{"Fibrinogen":[0],"degradation":[1],"products":[2],"(FDP)":[3],"in":[4,14,63,73,95,115],"a":[5],"dose":[6],"dependent":[7],"manner":[8],"potentiated":[9,68],"the":[10,15,27,32,39,48,53,64,69,74,83,93,100,106,110,116,120],"action":[11,96],"of":[12,34,55,60,71,85,97,102,109,122],"amphetamine":[13,35,98,113],"tests":[16],"for":[17],"locomotor":[18],"activity":[19],"(Knoll's":[20],"motimeter)":[21],"and":[22,42,57,87,118],"stereotypy.":[23],"They":[24,66],"also":[25,67],"antagonized":[26],"haloperidol-induced":[28],"catalepsy.":[29],"FDP":[30,50,103],"increased":[31,58],"level":[33,54,114,121],"90":[36],"min":[37,46],"after":[38,47],"drug":[40],"administration,":[41],"depressed":[43,52],"it":[44],"120":[45],"treatment.":[49],"slightly":[51],"dopamine,":[56],"that":[59,92],"homovanillic":[61],"acid":[62],"striatum.":[65],"accumulation":[70],"noradrenaline":[72],"hippocampus,":[75],"produced":[76],"by":[77],"amphetamine,":[78],"but":[79],"did":[80],"not":[81],"affect":[82],"concentrations":[84],"dopamine":[86],"serotonin.":[88],"It":[89],"is":[90],"suggested":[91],"change":[94],"under":[99],"influence":[101],"depends":[104],"on":[105,112,119],"direct":[107],"effect":[108],"peptides":[111],"brain,":[117],"some":[123],"neuromediators.":[124]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2409347488","counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
